Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

Podcast – Neil Macey and Christy Paxman – Centralised High Risk Drug Monitoring

Podcast – Neil Macey and Christy Paxman – Centralised High Risk Drug Monitoring

FromThe General Practice Podcast


Podcast – Neil Macey and Christy Paxman – Centralised High Risk Drug Monitoring

FromThe General Practice Podcast

ratings:
Length:
21 minutes
Released:
Jan 16, 2023
Format:
Podcast episode

Description

  Ben welcomes both Neil Macey and Christy Paxman to his podcast this week to discuss Centralised High-Risk Drug Monitoring. Neil has been a guest on the podcast before when he discussed a centralised PCN, and he is back to discuss further innovations. In today's episode, Neil and Christy explain how they came up with the plan of Care Coordinators within the Pharmacy Teams and rolling out Centralised High-Risk Drug Monitoring.    Introduction (0.09)   Recap of Suffolks PCNs (0.30)   Christy Paxman’s role (1.18)   Care Coordinators in Pharmacy teams & Centralised High-Risk Drug Monitoring (1.36)   The plan… (2.46)   The results of your Centralised model (4.10)   Discussions around the centralised model (4.52)   How many Practices were involved? (5.23)   What’s the process? (6.05)   How has the process been adapted over time? (9.06)   Feedback from Practices… (10.15)   Checking and Monitoring (11.58)   Initial discoveries.. (11.54)   Feedback from Practices & Patients.. (14.52)   Managing time… (16.24)   Next steps… (18.18)   What advice do you have for other PCNs? (19.25)   Graph showing the site-by-site progress that has been made since introducing the HRDM service up until 17/11/2 For all enquiries about the Ockham podcast, please contact Ben Gowland here.  
Released:
Jan 16, 2023
Format:
Podcast episode

Titles in the series (100)

Ben Gowland talks to those making real change happen in healthcare, getting underneath what they did, how they managed to do it, and the challenges they faced along the way